PharmaTelevision - BIA Chairman, Tim Edwards unveils new initiatives for growth of UK Biotechnology industry

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BIA Chairman, Tim Edwards unveils new initiatives for growth of UK Biotechnology industry

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Tim Edwards, Chairman of BIA

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Role as Chairman of BIA

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here in Oxford. On this show I have Tim Edwards, who is the Chairman of the BIA Association here in the UK, welcome.

Tim Edwards:

Thank you Fintan and good morning.

Fintan Walton:

Good morning to you, it's actually the BioIndustry Association lets correct on that now the BIA is like a number of a countrywide or country specific associations which are there to support the biotechnology industry and of course in this case support the biotechnology industry in the UK. You've taken on the role of a Chairman of the BIA some would argue at a pretty tough time in the industry primarily because of lack of funding and so forth, so just from a personal point of view you are also CEO of Cellzome what was it that made you want to join BIA and take on this role as Chairman?

Tim Edwards:

Well I've been a board member for about three-years before and in simply put I was asked to do it and I think it's important to take on these roles if you are asked it's a sense of duty and I feel strongly about the biotech sector and trying to make a broader contribution in my role as the CEO of Cellzome to it.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Tim Edwards

Chairman

Tim Edwards is currently President and Chief Executive Officer of Cellzome, a privately owned drug discovery company identifying a new generation of kinase-targeted drugs to treat inflammatory diseases, using its leading Kinobeads technology. Previously, Tim had various positions at British Biotech plc including Board Director and Acting CEO, and before that was an Investment Banker in London specializing in the healthcare sector. This followed a 14-year period as an entrepreneur in other industrial sectors, managing and developing three privately-held businesses in which he was a major shareholder. Tim is Chairman of the BioIndustry Association, the trade association for innovative enterprises in the UK's bioscience sector; Chairman of The Mulberry Bush Organization, a charity founded in 1948 providing therapeutic and residential care for children aged 5-12 with severe emotional and behavioral difficulties; and a Fellow of the RSA, a charity founded in 1754 which drives ideas, innovation and social change. From 2005-2007, Tim was Chairman of ReOx Limited, a biotech company spun out of the University of Oxford by Peter Ratcliffe FRS and others from the Wellcome Trust Centre for Human Genetics.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

BioIndustry Association

BioIndustry Association is the trade association for innovative enterprises in the UK's bioscience sector. Established in 1989, our mission is to encourage and promote a thriving, financially sound sector of the UK economy, built upon developments across the biosciences. We seek to create economic growth, increase employment opportunities, and expand the skills base. BioIndustry Association (BIA) represent 265 members, the majority of which are involved in realizing the human health benefits that bioscience promises. Our headquarters are in central London.